Abstract

Typhoid is a major public health threat, particularly in areas lacking access to clean water, proper nutrition, and hygienic practices. The emergence of antibiotic resistance, inaccessibility of vaccines to the global south, and asymptomatic carriers of Salmonella typhi (S. typhi) have made tackling the scourge of typhoid a major challenge. Plant-based antimicrobial compounds have opened a new avenue for effectively managing typhoid by minimizing drug-related side effects and targeting the resistant strains of typhoidal salmonella cost-effectively. This review article contains many such candidates, who can potentially modify the typhoid treatment guidelines like Azadirachta indica, Canarium schweinfurthii-derived scopoletin, and Punic granatum, and those that target the resistant strains of S. typhi, like Amaranthus hybridus, and Quercus infectoria and Phyllanthus emblica. The article will also shed light on the challenges and promises associated with phytocompound extraction and standardization as the researchers navigate the uncharted waters of alternative medicinal sources.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call